Suresh Patankar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Suresh Patankar has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Satyen Dobhada
Department of Urology, King George's Medical University, Lucknow (UP), India
3 shared publicationsManish Bhansali
Department of Urology, King George's Medical University, Lucknow (UP), India
2 shared publicationsArun Jamkar
Department of Surgery, B.J. Medical College and Sassoon General Hospital, Pune
1 shared publication- Gaurang R Shah
Jivdaya Hospital, Dharmoday bldg, Jivdaya lane, L.B.S. Marg, Ghatkopar (West), Mumbai 400 086, India
1 shared publication - Manojkumar V Chaudhari
Bhaghirathi Medical Foundation, 169, Parvati gaon, Pune, 400 009, India
1 shared publication Navneet A Sonawane
Clinical Operations, Vedic Lifesciences Pvt. Ltd., B-118, Morya House, Link Road, Andheri (West), Mumbai, 400 053, India
1 shared publication
Latest Publications
- Open Access
- 15 September 2012
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 12 (1) , 155
Evaluation of a multi-herb supplement for erectile dysfunction: a randomized double-blind, placebo-controlled study
Background: Evidence is lacking for multi-ingredient herbal supplements claiming therapeutic effect in sexual dysfunction in men. We examined the safety and efficacy of VigRX Plus (VXP) – a proprietary polyherbal preparation for improving male sexual function, in a double blind, randomized placebo-controlled, parallel groups, multi-centre study. Methods: 78 men aged 25–50 years of age; suffering from mild to moderate erectile dysfunction (ED), participated in this study. Subjects were randomized to receive VXP or placebo at a dose of two capsules twice daily for 12 weeks. The international index of erectile function (IIEF) was the primary outcome measure of efficacy. Other efficacy measures were: Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS), Serum testosterone, Semen analysis, Investigator’s Global assessment and Subjects’ opinion. Results: In subjects receiving VXP, the IIEF-Erectile Function (EF) scores improved significantly as compared to placebo. After 12 weeks of treatment, the mean (sd) IIEF-EF score at baseline increased from 16.08 (2.87) to 25.08 (4.56) in the VXP group versus 15.86 (3.24) to 16.47 (4.25) in the placebo group (P < 0.0001). Similar results were observed in each of the remaining four domains of the IIEF (orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction).There was a significant difference for VXP versus placebo comparison of mean (sd) EDITS scores of patients: 82.31(20.23) vs 36.78(22.53) and partners :(82.75(9.8) vs 18.50(9.44);P < 0.001. Thirty-five out of 39 (90%) subjects from the VXP group and one (3%) from the placebo group wished to continue with the treatment they received. Investigator’s global assessment rated VXP therapy as very good to excellent in more than 50% patients and placebo therapy as fair to good in about 25% of patients. Incidence of side effects and subject’s rating for tolerability of treatment was similar in both groups. Conclusions: VigRX Plus was well tolerated and more effective than placebo in improving sexual function in men. Trial Registration: Clinical Trial Registry India, CTRI/2009/091/000099, 31-03-2009
- 15 September 2012
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 12 (1) , 155
Open AccessEvaluation of a multi-herb supplement for erectile dysfunction: a randomized double-blind, placebo-controlled study
Background: Evidence is lacking for multi-ingredient herbal supplements claiming therapeutic effect in sexual dysfunction in men. We examined the safety and efficacy of VigRX Plus (VXP) – a proprietary polyherbal preparation for improving male sexual function, in a double blind, randomized placebo-controlled, parallel groups, multi-centre study. Methods: 78 men aged 25–50 years of age; suffering from mild to moderate erectile dysfunction (ED), participated in this study. Subjects were randomized to receive VXP or placebo at a dose of two capsules twice daily for 12 weeks. The international index of erectile function (IIEF) was the primary outcome measure of efficacy. Other efficacy measures were: Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS), Serum testosterone, Semen analysis, Investigator’s Global assessment and Subjects’ opinion. Results: In subjects receiving VXP, the IIEF-Erectile Function (EF) scores improved significantly as compared to placebo. After 12 weeks of treatment, the mean (sd) IIEF-EF score at baseline increased from 16.08 (2.87) to 25.08 (4.56) in the VXP group versus 15.86 (3.24) to 16.47 (4.25) in the placebo group (P < 0.0001). Similar results were observed in each of the remaining four domains of the IIEF (orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction).There was a significant difference for VXP versus placebo comparison of mean (sd) EDITS scores of patients: 82.31(20.23) vs 36.78(22.53) and partners :(82.75(9.8) vs 18.50(9.44);P < 0.001. Thirty-five out of 39 (90%) subjects from the VXP group and one (3%) from the placebo group wished to continue with the treatment they received. Investigator’s global assessment rated VXP therapy as very good to excellent in more than 50% patients and placebo therapy as fair to good in about 25% of patients. Incidence of side effects and subject’s rating for tolerability of treatment was similar in both groups. Conclusions: VigRX Plus was well tolerated and more effective than placebo in improving sexual function in men. Trial Registration: Clinical Trial Registry India, CTRI/2009/091/000099, 31-03-2009
- Open Access
- 1 January 2012
- Published by Medknow in Journal of Minimal Access Surgery
- Vol. 8 (1) , 13-5
Laparoscopic resection of extra-adrenal pheochromocytoma in paediatric age
Today, in the era of minimally invasive surgery, paediatric laparoscopy has become widely popular. Extra-adrenal pheochromocytoma is a very rare entity, especially in the paediatric age group and utility of the laparoscopic approach is not established in this population. Early diagnosis and surgical excision are integral part of treatment of childhood pheochromocytoma. We present a case study of a child with hormonally active extra-adrenal pheochromocytoma that was resected laparoscopically. Laparoscopic approach provides excellent exposure with magnification and allows proper identification of the tumour and its relation to surrounding structures; complete resection of tumour was achieved with adequate vascular control. With our initial experience, we suggest laparoscopic resection is an appropriate and feasible tool in such cases.
- 1 January 2012
- Published by Medknow in Journal of Minimal Access Surgery
- Vol. 8 (1) , 13-5
Open AccessLaparoscopic resection of extra-adrenal pheochromocytoma in paediatric age
Today, in the era of minimally invasive surgery, paediatric laparoscopy has become widely popular. Extra-adrenal pheochromocytoma is a very rare entity, especially in the paediatric age group and utility of the laparoscopic approach is not established in this population. Early diagnosis and surgical excision are integral part of treatment of childhood pheochromocytoma. We present a case study of a child with hormonally active extra-adrenal pheochromocytoma that was resected laparoscopically. Laparoscopic approach provides excellent exposure with magnification and allows proper identification of the tumour and its relation to surrounding structures; complete resection of tumour was achieved with adequate vascular control. With our initial experience, we suggest laparoscopic resection is an appropriate and feasible tool in such cases.
- 1 September 2006
- Published by SAGE Publications in Journal of Endourology
- Vol. 20 (9) , 639-641
Case Report: Laparoscopic Heminephrectomy in a Horseshoe Kidney Using Bipolar Energy
Aberrant vasculature, functional parenchyma in the isthmus, and abnormal location are all unique features of horseshoe kidney that present technical challenges to laparoscopic management of disease. A 52-year-old man presented with a large renal calculus in a poorly functioning left moiety of a horseshoe kidney and underwent laparoscopic heminephrectomy. The ismthus, which had 2.5 to 3.0 cm of functioning parenchyma, was divided using the PlasmaKinetic Superpulse Generator (Gyrus). No additional hemostatic measure was required. The total operative time was 140 minutes with an estimated blood loss of 160 mL. At follow-up, the right moiety and remaining isthmus exhibited normal function with no extravasation.
- 1 September 2006
- Published by SAGE Publications in Journal of Endourology
- Vol. 20 (9) , 639-641
Case Report: Laparoscopic Heminephrectomy in a Horseshoe Kidney Using Bipolar Energy
Aberrant vasculature, functional parenchyma in the isthmus, and abnormal location are all unique features of horseshoe kidney that present technical challenges to laparoscopic management of disease. A 52-year-old man presented with a large renal calculus in a poorly functioning left moiety of a horseshoe kidney and underwent laparoscopic heminephrectomy. The ismthus, which had 2.5 to 3.0 cm of functioning parenchyma, was divided using the PlasmaKinetic Superpulse Generator (Gyrus). No additional hemostatic measure was required. The total operative time was 140 minutes with an estimated blood loss of 160 mL. At follow-up, the right moiety and remaining isthmus exhibited normal function with no extravasation.
- 1 August 2006
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 16 (4) , 386-389
Vesicovaginal Fistula with Secondary Vaginal Stones
Purpose: We report a rare case of a vesicovaginal fistula associated with secondary vaginal stones that was managed totally endoscopically. Materials and Methods: A 52-year-old woman presented with urinary incontinence and perineal pain. On subsequent evaluation, we found a vesicovaginal fistula associated with secondary vaginal stones caused by a retained gauze. Management involved vaginoscopy, intracorporeal shock wave lithotripsy for vaginal stones, and removing retained medical gauze. We performed cystoscopy, laparoscopic cystotomy, transabdominal Foley catheterization of the vesicovaginal fistula for traction, injection of diluted adrenaline-saline solution for better dissection, dissection of the bladder from the vagina, tension-free closure of the bladder and vaginal defects, and closure of the cystotomy. Results: Operative time was 155 minutes and blood loss was 60 mL. The patient was discharged on postoperative day 3, and catheterization time was 14 days. At 3-month follow-up, the patient was fully continent. Conclusion: To our knowledge, this is the first reported case of a vesicovaginal fistula associated with secondary vaginal stones which was managed totally endoscopically. We believe that this is a feasible and efficacious approach for the management of such cases.
- 1 August 2006
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 16 (4) , 386-389
Vesicovaginal Fistula with Secondary Vaginal Stones
Purpose: We report a rare case of a vesicovaginal fistula associated with secondary vaginal stones that was managed totally endoscopically. Materials and Methods: A 52-year-old woman presented with urinary incontinence and perineal pain. On subsequent evaluation, we found a vesicovaginal fistula associated with secondary vaginal stones caused by a retained gauze. Management involved vaginoscopy, intracorporeal shock wave lithotripsy for vaginal stones, and removing retained medical gauze. We performed cystoscopy, laparoscopic cystotomy, transabdominal Foley catheterization of the vesicovaginal fistula for traction, injection of diluted adrenaline-saline solution for better dissection, dissection of the bladder from the vagina, tension-free closure of the bladder and vaginal defects, and closure of the cystotomy. Results: Operative time was 155 minutes and blood loss was 60 mL. The patient was discharged on postoperative day 3, and catheterization time was 14 days. At 3-month follow-up, the patient was fully continent. Conclusion: To our knowledge, this is the first reported case of a vesicovaginal fistula associated with secondary vaginal stones which was managed totally endoscopically. We believe that this is a feasible and efficacious approach for the management of such cases.
- 1 March 2006
- Published by SAGE Publications in Journal of Endourology
- Vol. 20 (3) , 215-219
PlasmaKinetic Superpulse Transurethral Resection versus Conventional Transurethral Resection of Prostate
Purpose: To compare the efficacy and safety of the PlasmaKinetic (PK) Superpulse system with that of conventional transurethral resection of the prostate (TURP) in terms of restoration of urinary flow and early postoperative course. Patients and Methods: One hundred five men older than 45 years with lower-urinary tract symptoms associated with benign prostatic hyperplasia (BPH) were randomized, 51 undergoing standard TURP with glycine as the irrigation fluid and 53 TURP with the PK Superpulse system with normal saline as irrigant. The operative time, intraoperative blood loss, catheter time, change in serum electrolytes (particularly sodium), and uroflowmetry and American Urological Association (AUA) Symptom Scores were compared. Results: The blood loss as well as the catheter time observed in the PK Superpulse arm were significantly less than those in the conventional-TURP arm. The mortality rate was 0 in both the arms. The mean operative time was less in the PK Superpulse arm, although not significantly so. Hyponatremia was statistically insignificant. Significant changes were observed in the AUA Scores in both arms. Conclusion: The PK Superpulse system provides faster removal of tissue in a bloodless field with better views and a safer environment of saline irrigation with efficacy comparable to that of conventional TURP. However, further randomized trials with extended follow-up may be needed to better define the role of the PK Superpulse system in treating patients with symptomatic BPH.
- 1 March 2006
- Published by SAGE Publications in Journal of Endourology
- Vol. 20 (3) , 215-219
PlasmaKinetic Superpulse Transurethral Resection versus Conventional Transurethral Resection of Prostate
Purpose: To compare the efficacy and safety of the PlasmaKinetic (PK) Superpulse system with that of conventional transurethral resection of the prostate (TURP) in terms of restoration of urinary flow and early postoperative course. Patients and Methods: One hundred five men older than 45 years with lower-urinary tract symptoms associated with benign prostatic hyperplasia (BPH) were randomized, 51 undergoing standard TURP with glycine as the irrigation fluid and 53 TURP with the PK Superpulse system with normal saline as irrigant. The operative time, intraoperative blood loss, catheter time, change in serum electrolytes (particularly sodium), and uroflowmetry and American Urological Association (AUA) Symptom Scores were compared. Results: The blood loss as well as the catheter time observed in the PK Superpulse arm were significantly less than those in the conventional-TURP arm. The mortality rate was 0 in both the arms. The mean operative time was less in the PK Superpulse arm, although not significantly so. Hyponatremia was statistically insignificant. Significant changes were observed in the AUA Scores in both arms. Conclusion: The PK Superpulse system provides faster removal of tissue in a bloodless field with better views and a safer environment of saline irrigation with efficacy comparable to that of conventional TURP. However, further randomized trials with extended follow-up may be needed to better define the role of the PK Superpulse system in treating patients with symptomatic BPH.